IA
KRON

IndexIQ Advisors’s Kronos Bio KRON Stock Holding History

IndexIQ Advisors’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$378K Buy
+52,218
New +$445K 0.01% 908

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

IndexIQ Advisors's KRON Position: Q1 2022 in Review

IndexIQ Advisors opened a new position in Kronos Bio (KRON) in Q1 2022: 52,218 shares worth $378K. The stake represents 0.01% of the portfolio and ranks #908 among its holdings.

96 funds tracked by Wall St. Rank hold KRON as of Q1 2022.

  • IndexIQ Advisors held 52,218 shares of Kronos Bio worth $378K as of Q1 2022.
  • Kronos Bio was a new IndexIQ Advisors position in Q1 2022.
  • Kronos Bio made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #908 holding.
  • 96 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.